Chemotherapy or No Chemotherapy in Clear Margins after Neoadjuvant Chemoradiation in Locally Advanced Rectal Cancer: CHRONICLE. A Randomised Phase III Trial of Control vs. Capecitabine plus Oxaliplatin

Clinical Oncology

Volumn 19, Issue 5, 2007, Pages 327-329

  Glynne Jones, R ^a   Meadows, H ^b   Wood, W ^b  

^a MOUNT VERNON CANCER CENTRE   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; CAPECITABINE; FLUOROPYRIMIDINE DERIVATIVE; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; OXALIPLATIN; TEGAFUR; URACIL;

ADJUVANT THERAPY; ADVANCED CANCER; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER RECURRENCE; CANCER RELAPSE; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; COLON CANCER; CONTROLLED CLINICAL TRIAL; DISEASE FREE SURVIVAL; DRUG RESPONSE; DRUG SENSITIVITY; EDITORIAL; HISTOPATHOLOGY; HUMAN; MULTIPLE CYCLE TREATMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERALL SURVIVAL; PREOPERATIVE RADIOTHERAPY; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; RECTUM CANCER; RECTUM TUMOR; RECURRENCE RISK; SURVIVAL TIME; TREATMENT DURATION;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CLINICAL TRIALS, PHASE III; COMBINED MODALITY THERAPY; DEOXYCYTIDINE; FLUOROURACIL; MULTICENTER STUDIES; NEOADJUVANT THERAPY; ORGANOPLATINUM COMPOUNDS; RANDOMIZED CONTROLLED TRIALS; RECTAL NEOPLASMS;

EID: 34248585127     PISSN: 09366555     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clon.2007.03.003     Document Type: Editorial

References (24)

1. Mawdsley S., Glynne-Jones R., Grainger J., et al. Can the histopathological assessment of the circumferential margin following pre-operative pelvic chemo-radiotherapy for T3/4 rectal cancer predict for three year disease free survival?. Int J Radiat Oncol Biol Phys 63 (2005) 745-752
2. Sebag-Montefiore D., Glynne-Jones R., Mortensen N., et al. Pooled analysis of outcome measures including histopathological R0 resection rate after preoperative chemoradiation for locally advanced rectal cancer. Colorectal Dis 7 Suppl 1 (2005) 7 (abstract oral 20)
3. Brown G., Radcliffe A.G., Newcombe R.G., et al. Preoperative assessment of prognostic factors in rectal cancer using high-resolution magnetic resonance imaging. Br J Surg 90 (2003) 355-364
4. Daniels I. MRI predicts surgical resection margin status in patients with rectal cancer: results from the Mercury Study Group. Clin Oncol 16 (2004) S45-S46
5. Fietkau R., Barten M., Klautke G., et al. Postoperative chemotherapy may not be necessary for patients with ypN0-category after neoadjuvant chemoradiotherapy of rectal cancer. Dis Colon Rectum 49 9 (2006) 1284-1292
6. Mohiuddin N., Hayne M., Regine W., et al. Prognostic significance of post-chemoradiation stage following preoperative chemotherapy and radiation for advanced/recurrent rectal cancers. Int J Radiat Oncol Biol Phys 48 4 (2000) 1075-1080
7. Capirci C., Valentini V., Rodel F., et al. Prognostic value of pathological complete response after neoadjuvant radiochemotherapy in locally advanced rectal cancer: a pooled analysis on 566 patients. Radiother Oncol 81 Suppl 1 (2006) S76-S77 (abstract 193)
8. Janjan N.A., Abbruzzese J., Pazdur R., et al. Prognostic implications of response to preoperative infusional chemoradiation in locally advanced rectal cancer. Radiother Oncol 51 2 (1999) 153-160
9. Hughes R., Glynne-Jones R., Grainger J., et al. Can pathological complete response in the primary tumour following pre-operative pelvic chemoradiotherapy for T3-T4 rectal cancer predict for sterilisation of pelvic lymph nodes, a low risk of local recurrence and the appropriateness of local excision?. Int J Colorectal Dis 21 1 (2006) 11-17
10. Bujko K., Kepka L., Michalski W., and Nowacki M. Does rectal cancer shrinkage induced by preoperative radio(chemo)therapy increase the likelihood of anterior resection? A systematic review of randomised trials. Radiother Oncol 80 1 (2006) 4-12
11. Sanfillipo N.J., Crane C.H., Skibber J., et al. T4 rectal cancer treated with preoperative chemoradiation to the posterior pelvis followed by multivisceral resection: patterns of failure and limitations of treatment. Int J Radiat Oncol Biol Phys 51 1 (2001) 176-183
12. Crane C., Thames H., Skibber J., et al. 5-FU based adjuvant chemotherapy given after neoadjuvant chemoradiation and surgery for rectal cancer improves survival only among responders. Eur J Cancer 37 Suppl 6 (2001) (abstract 1002)
13. Chan A.K., Wong A., Jenken D., et al. Is postoperative adjuvant chemotherapy necessary in locally advanced rectal cancers after preoperative chemoradiation?. Int J Radiat Oncol Biol Phys 60 Suppl (2004) S297 (abstract 1066)
14. Cionini L., Manfredi B., Sainato A., et al. Randomized study of postoperative chemotherapy (CT) after preoperative chemoradiation (CTRT) in locally advanced rectal cancer (LARC). Preliminary results. Eur J Cancer 37 Suppl 6 (2001) (abstract 1107)
15. Bosset J.F., Collette L., Calais G., et al. Chemotherapy with pre-operative radiotherapy in rectal cancer. New Engl J Med 355 (2006) 1114-1123
16. Akasu T., Moriya Y., Ohashi Y., Yoshida S., Shirao K., and Kodaira S. Adjuvant chemotherapy with uracil-tegafur for pathological stage III rectal cancer after mesorectal excision with selective pelvic lymphadenectomy: a multicentre randomised controlled trial. Jpn J Clin Oncol 36 4 (2006) 237-244
17. Law W.L., Ho J.W., Chan R., et al. Outcome of anterior resection for stage II rectal cancer without radiation: the role of adjuvant chemotherapy. Dis Colon Rectum 48 2 (2004) 218-226
18. Moertel C.G., Fleming T.R., Macdonald J.S., et al. Levamisole and fluorouracil for adjuvant chemotherapy of resected colon carcinoma. New Engl J Med 322 (1990) 352-358
19. Andre T., Boni C., Mounedji-Boudiaf L., et al. Oxaliplatin, fluorouracil as adjuvant treatment for colon cancer. New Engl J Med 23 (2004) 2343-2351
20. Wolmark N., Wieand H.S., Kuebler J.P., et al. A phase III trial comparing FULV to FULV + oxaliplatin in stage II or III carcinoma of the colon: results of NSABP Protocol C-07. Proc Am Sco Clin Oncol (2005) abstract 3500
21. Taal B.G., Van Tinteren H., Zoetmulder F.A., and NACCP group. Adjuvant 5FU plus levamisole in colonic or rectal cancer: improved survival in stage II and III. Br J Cancer 85 10 (2001) 1437-1443
22. Glimelius B., Dahl O., Cedermark B., et al. Adjuvant chemotherapy in colorectal cancer: a joint analysis by the Nordic Gastrointectinal Tumour Adjuvant Therapy Group. Acta Oncol 44 8 (2005) 904-912
23. The AXIS Collaborators. Randomised clinical trial of adjuvant radiotherapy and 5-fluorouracil infusion in colorectal cancer (AXIS). Br J Surg 90 10 (2003) 1200-1212
24. Saini A., Norman A.R., Cunningham D., et al. Twelve weeks of protracted venous infusion of fluoro-uracil (5FU) is as effective as 6 months of bolus 5FU and folinic acid as adjuvant treatment in colorectal cancer. Br J Cancer 88 (2003) 1859-1865